Navigation Links
Cancer Gene Mutations Not Uncommon in General Population

Cancer gene mutations are found in about one percent of the total general population, occurring more frequently than previously thought, and may be associated with various// types of cancers, according to researchers at Yale School of Medicine.

Published in the December 6 Journal of the National Cancer Institute (JNCI), the study looked for the presence and rate of BRCA 1 and BRCA 2 mutations in a population of women with newly diagnosed ovarian cancer. They screened not only for the most common mutations but also for variants that may be more rare or difficult to distinguish. They then calculated the incidence of those variants in the general population and in individuals with family members who have had cancer.

Previous research has shown that lifetime risks for breast, ovarian and other cancers are elevated for people carrying the BRCA1/2 mutations. The Yale team found that the lifetime risk to age 80 is not the same for all mutations and some mutations have higher and some lower risks for developing cancers.

“The exact nature of the level of risk for the particular mutations needs to be further explored,” said lead researcher Harvey Risch, M.D., professor in the Division of Chronic Disease Epidemiology in the Department of Epidemiology and Public Health at Yale School of Medicine. “This study is an important first step in that direction.”

Risch and his co-authors screened 1,171 women in Ontario, Canada with ovarian cancer and assessed their risk of cancer based on whether or not they carried a mutation. The women were then asked about cancers among their 8,680 first-degree relatives—their parents, siblings and children.

“We found that cancer risk differed for each gene according to the mutation’s position in the gene,” said Risch, who is also a member of the Yale Cancer Center. “When choosing which individuals to screen for mutations, we should consider all kinds of cancers among family members, not jus t breast and ovary and not just cancers in females.”

Risch and his team will follow up the study with a larger population sample in order to better understand the individual mutations and their differences.

Source-Yale Universiy

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:

(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
(Date:6/23/2016)... 2016  Guerbet announced today that it has been ... Award . One of 12 suppliers to ... its support of Premier members through exceptional local customer ... commitment to lower costs. ... our outstanding customer service from Premier," says Massimo ...
Breaking Medicine Technology: